Fall 2024 Announcements 1. FY25 pricing list is now available for your review.  These prices will be effective on 10/1/2024. Please note some prices have increased.   *Dry Ice charges- Effective on 10/1/2024 charges of Dry Ice will occur after 1 scoop is used. (1 scoop is approximately 2 lbs. If needed during a visit […]

The Center for Clinical Investigations is happy to provide video tours of three outpatient locations on the Brigham and Women’s Hospital Campus.   Ambulatory Clinical Center (ACC) Richardson Fuller Building, 221 Longwood Avenue: here   Clinical Trials Center (CTC) Peter Bent Brigham, 15 Francis Street: here   Clinical Trials Hub (CTH) Hale Building for Transformative Medicine, 60

Beginning Monday 5/13, the process for submitting overbook request for MRB processing will be changing, to better streamline our process. When CTC room is not available, a normal overbook request may be submitted. *Please be sure to provide alternate dates and time when submitting an overbook request. When MRB lab tech is not available, please

Community Engaged Research Toolkit   (An Essential Guidebook and Toolkit for Researchers and Communities)   Please see linked Toolkit developed by the Clinical Research Center at Beth Israel Deaconess Medical Center with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center to provide resources to the research community to “build trust, enlist

Are you utilizing the resources at the CCI effectively? Ensure smooth operations by guaranteeing your staff is trained and equipped with access to our scheduler. Our comprehensive scheduler training, conveniently available on HealthStream, ensures seamless coordination and maximum efficiency. Simply search the catalog for ‘BWHC CCI Scheduler’ and empower your team to streamline scheduling processes.

For study teams: Please be sure to site the Clinical Research Center grants from NIH-NCATS when publishing any papers that received support from the CRC.  Please also send any CCI publication citations to cci@bwh.harvard.edu , as this information is also required for the CCI/Catalyst Progress reports to the NIH. Note that we are only referring to Federal

The CCI recently opened a BL2+ lab on BWH’s main campus to process infectious samples, including COVID+ samples. This lab has 2 biosafety cabinets, centrifuges with sealed rotors, and an incubator. The equipment will allow investigators to study biological sampling of blood, nasal and lower respiratory secretions in order to identify immunophenotypic and genomic features.